Safety and efficiency of Wharton’s Jelly-derived mesenchymal stem cell administration in patients with traumatic brain injury: First results of a phase I study

Figure 1 The changes observed in the patients’ average scores of Functional Independence Measure Motor and Cognitive Score values and Modified Ashworth Score right and left values before the procedure, 1^st wk after the procedure, and at the 1^st month, 2^nd month, 6^th month and 1^st year. A: The changes observed in the patients’ average scores of Functional Independence Measure Motor and Cognitive Score values before the procedure, 1^st wk after the procedure, and at the 1^st month, 2^nd month, 6^th month and 1^st year; B: The changes observed in the patients’ average scores of Modified Ashworth Score right and left values before the procedure, 1^st wk after the procedure, and at the 1^st month, 2^nd month, 6^th month and 1^st year. FIM: Functional Independence Measure.

Figure 2 The changes observed in the average scores of the patients before the procedure, at the 1^st wk, 1^st month, 2^nd month, 6^th month and 1^st year after the procedure, regarding the Medical Research Council muscle strength scale right and left values. MRC: Medical Research Council.

Figure 3 Changes observed in the pretest and posttest averages of the patients’ Karnofsky performance scale values.